Featured in CNN: COVID-19 Antibody Therapy Could Be Available This Year, Biotech CEO Says

“We’re moving at breakneck speed,” said Carl Hansen, CEO of AbCellera. “It’s like running 100 meters in two seconds.” 

Read full coverage on CNN.

PARTNERSHIP

Together we can make game-changing discoveries.

Let's talk